AVITA Medical, Inc. (RCEL)
Automate Your Wheel Strategy on RCEL
With Tiblio's Option Bot, you can configure your own wheel strategy including RCEL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol RCEL
- Rev/Share 2.84
- Book/Share -0.4889
- PB -8.8253
- Debt/Equity -3.4586
- CurrentRatio 0.5791
- ROIC -1.2382
- MktCap 114944567.0
- FreeCF/Share -1.5944
- PFCF -2.7341
- PE -2.2061
- Debt/Assets 0.767
- DivYield 0
- ROE 279.9077
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | RCEL | BTIG Research | Neutral | Sell | -- | $3 | Aug. 8, 2025 |
| Initiation | RCEL | D. Boral Capital | -- | Buy | -- | $25 | Dec. 24, 2024 |
News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
Published: September 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm
Published: September 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
Investors can contact the law firm at no cost to learn more about recovering their losses
Read More
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Published: September 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) investors concerning the Company's possible violations of the federal securities laws.
Read More
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Published: September 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) on behalf of investors concerning the Company's possible violations of federal securities laws.
Read More
INVESTOR ALERT: Investigation of AVITA Medical, Inc. (RCEL) Announced by Holzer & Holzer, LLC
Published: August 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
ATLANTA, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether AVITA Medical, Inc. (“AVITA” or the “Company”) (NASDAQ: RCEL) complied with federal securities laws. On August 7, 2025, AVITA reported second quarter 2025 results and revised its 2025 guidance, stating that the Company experienced a “significant headwind from a temporary gap in Medicare Administrative Contractor (MAC) payments to providers for the use of our flagship RECELL® System, which led to a weakening in demand. Multiple MACs initiated payments in July with resolution expected in Q3.” Following this report, the price of the Company's stock dropped.
Read More
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Published: August 21, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON AVITA MEDICAL, INC. (RCEL), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On August.
Read More
AVITA Medical to Host Investor Webinar Briefing
Published: August 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
VALENCIA, Calif., Aug. 10, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O'Toole, Chief Financial Officer, on August 14, 2025, at 9 AM Australian Eastern Daylight Time (August 13 at 4 PM U.S. Pacific Standard Time).
Read More
AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript
Published: August 08, 2025 by: Seeking Alpha
Sentiment: Neutral
AVITA Medical, Inc. (NASDAQ:RCEL ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Ben Atkins - Corporate Participant David O'Toole - Chief Financial Officer James M. Corbett - CEO, President & Executive Director Conference Call Participants Joshua Thomas Jennings - TD Cowen, Research Division Ross Everett Osborn - Cantor Fitzgerald & Co., Research Division Operator Good day, and thank you for standing by.
Read More
AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript
Published: May 08, 2025 by: Seeking Alpha
Sentiment: Neutral
AVITA Medical, Inc. (NASDAQ:RCEL ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director, Investor Relations Jim Corbett - Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Chris Kallos - MST Access Operator Good day, and thank you for standing by. Welcome to AVITA Medical First Quarter 2025 Earnings Conference Call.
Read More
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
AVITA Medical announced that Jim Corbett, CEO, will present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025, at 11:50 a.m. Eastern Time.
Read More
After Sales Rebound In January, AVITA Is Set Up For A Monster Year
Published: February 18, 2025 by: Seeking Alpha
Sentiment: Positive
After Sales Rebound In January, AVITA Is Set Up For A Monster Year
Read More
AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Neutral
AVITA Medical, Inc. (NASDAQ:RCEL ) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Matthew Park - Cantor Fitzgerald Ryan Zimmerman - BTIG Brooks O'Neil - Lake Street Capital Markets Joshua Jennings - TD Cowen Operator Good day, and thank you for standing by. Welcome to the AVITA Medical Fourth Quarter 2024 Earnings Conference Call.
Read More
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
VALENCIA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Read More
About AVITA Medical, Inc. (RCEL)
- IPO Date 2012-05-14
- Website https://www.avitamedical.com
- Industry Medical - Devices
- CEO James M. Corbett
- Employees 260